TE_16731

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family SVA_D
TE superfamily SVA
TE class Retroposon
Gene SNX10, -
Class Chimeric, Intergenic
Coding Non-coding
Tumor-specific score 188.98
Counts of samples TCGA_tumor:502; TCGA_normal:2; GTEx:0
TSS chr7(+):26261512



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_16731.31 SNX10 Chimeric Non-coding Non-coding chr7(+):26261513,26262126,26346420,26346466,26360975,26361061,26364535,26364635,26365047,26365145,26371850,26372033,26372491,26372511
teRNA_16731.32 SNX10 Chimeric Non-coding Non-coding chr7(+):26261513,26262126,26346420,26346466,26360975,26361061,26364535,26364635,26365047,26365145,26370141,26370206,26371821,26372033,26372491,26372511
teRNA_16731.33 SNX10 Chimeric Non-coding Non-coding chr7(+):26261513,26262126,26346420,26346466,26354057,26354184,26357007,26357127,26360975,26361061,26364535,26364635,26365047,26365145,26371821,26372033,26372491,26372511


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).